Nerlynx drug for early breast cancer treatment

Breast cancer starts when cells in the breast begin to grow out of control. The cancers can start from different parts of the breast. It can start from the ducts that carry milk to the nipple or in the glands that make breast milk.

The U.S. Food and Drug Administration FDA has approved Nerlynx a once-daily oral tyrosine kinase inhibitor for the extended adjuvant treatment of adult patients with early stage HER2-overexpressed/amplified breast cancer.

Nerlynx is a prescription medicine used to treat adults who have early-stage breast cancer, which is HER2-positive and has previously been treated with the medicine trastuzumab.

Nerlynx may cause serious side effects like diarrhea, liver problems, fatigue,
vomiting, fever, rash, right upper abdominal pain, weight loss and urinary tract infection UTI.

Pregnant women, nursing mother and women planning to get pregnant can not use Nerlynx.
            haleplushearty.blogspot.com
         

Facts about male breast cancer

1. Male breast cancer accounts for about one percent of all breast cancer.

2. High estrogen hormone and family history increase the risk of breast cancer in men.

3. A lump under the nipple is the most common symptom of male breast cancer.

4. Most cases of breast cancer in men develop in men who are 60 years and above.

5. Infiltrating ductal carcinoma is the most common type of male breast cancer.

6. About 85 percent of breast cancer in men have estrogen receptor on their cell membrane

7. A member of mutated genes have been linked to increase risk of male breast cancer.

8. Causes of male breast cancer is unknown

9. Early detection can prevent the spread of male breast cancer

10. Living healthy lifestyle can prevent male breast cancer.